GILEAD SCIENCES, INC. — Director's Dealing 2013

Nov 25, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2013-11-22

Reporting Person: YOUNG KEVIN (EVP, Commercial Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-11-22	Common Stock	M	75000	$16.395	Acquired	236840	Direct
2013-11-22	Common Stock	S	37000	$73.9039	Disposed	199840	Direct
2013-11-22	Common Stock	S	38000	$74.7659	Disposed	161840	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-11-22	Non-Qualified Stock Optin (right to buy)	$16.395	M	75000	Disposed	2017-01-22	Common Stock (75000)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.

F3: Sale prices reported for the transactions reported here range from $73.35 to $74.33. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F4: Sale prices reported for the transactions reported here range from $74.37 to $74.90. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request